NDMA Policy Forum 2020

NDMA Policy Forum 2020

The Policy Forum process allows NDMA members to participate in the discussion process. It is designed to allow broad member input, feedback and ideas on critical health policy issues facing North Dakota physicians and care provided to their patients.

NDMA encourages all NDMA members to attend the Policy Forum held at this year's ONLINE ANNUAL MEETING on Tuesday, October 13, 2020 beginning at 5:00 pm; the policy forum is scheduled to be held from 5:45 to 7:00 pm.


Topics for the October 13 Policy Forum include the following:

  • Racial Health InequityThis is a policy position supporting racial health equity. Nationwide, this has become an issue, particularly during the pandemic. Recent studies show that racial and ethnic minorities experience a lower quality of health care and are less likely to receive routine medical care and face higher rates of morbidity and mortality than non-minorities. NDMA should adopt a policy statement opposing racially and culturally based disparities in health care in North Dakota and support initiatives to alleviate these disparities in North Dakota. Learn more.
  • Telemedicine Payment ParityThis is a policy position encouraging telemedicine payment parity. In 2017, the North Dakota Legislature passed coverage parity, which is not payment parity. Payment parity is necessary to have a sustainable model. NDMA should support telemedicine payment parity in the 2020 ND Legislative Session. Learn more.
  • COVID-19 Foundation for Healthy Habits AppealThis unprecedented pandemic has presented many issues for our nation, including physicians and their patients. This topic proposes to use the foundational elements of COVID-19 healthy habits summarized into a white paper document; then used to advocate for patient health. This tool can be used to recruit physicians to adopt and promote the white paper. Physician recruitment may be conducted in a variety of avenues, such as promoting through online signatures or one-on-one recruitment. Learn more and review the letter here.

Sorry no Tweets at this time

Follow Us!